The LEF1 gene is frequently mutated in its NH2 terminus in human sebaceous tumors, and these mutations play a dual role in skin cancer, specifying tumor type by inhibiting Wnt signaling and acting as a tumor promoter by preventing induction of p53 [230]. This evidence concerns the gene LEF1 and neoplasm.